Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany

OBJECTIVE: Examine cost-driving factors of schizophrenia in Germany for patients prior- and post-switch from an oral antipsychotic therapy to aripiprazole-depot and perform a budget impact analysis (BIA) referring to the context of German health care. METHODS: A single-armed, retrospective, non-inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Potempa, Christoph, Rychlik, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755603/
https://www.ncbi.nlm.nih.gov/pubmed/30470936
http://dx.doi.org/10.1186/s13561-018-0215-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755603/
https://www.ncbi.nlm.nih.gov/pubmed/30470936
http://dx.doi.org/10.1186/s13561-018-0215-5

Ejemplares similares